Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment.

Breast cancer research and treatment - 1 Sept 2017

Liede Alexander, Mansfield Carol A, Metcalfe Kelly A, Price Melanie A, Snyder Carrie, Lynch Henry T, Friedman Sue, Amelio Justyna, Posner Joshua, Narod Steven A, Lindeman Geoffrey J, Evans D Gareth

Abstract excerpt

PURPOSE: Unaffected women who carry BRCA1 or BRCA2 mutations face difficult choices about reducing their breast cancer risk. Understanding their treatment preferences could help us improve patient counseling and inform drug trials. The objective was to explore preferences for various risk-reducing options among women with germline BRCA1/2 mutations using a discrete-choice experiment survey and to compare...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Germ-Line Mutation

Share to Health Surveys

Share to Risk Reduction Behavior

Share to Surveys and Questionnaires

Source

Open in PubMed Open full text

Identifiers

PMID: 28624978
DOI: 10.1007/s10549-017-4332-3
PMCID: PMC5543193

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment.PMID 28624978Read ↗

Counselling of path_BRCA carriers who are considering risk-reducing oophorectomy.Semantic proximity Read ↗

Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers.Semantic proximity Read ↗

Attitude of BRCA1/2 mutation carriers towards surgical risk reduction for breast, ovarian and uterine cancer: still much to be done.Semantic proximity Read ↗

Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study.Semantic proximity Read ↗

Breast Cancer Risk Reduction Decisions of the BRCA-Positive Patient: An Observational Study at a Single Institution.Semantic proximity Read ↗

Women's preferences for contralateral prophylactic mastectomy following unilateral breast cancer: What risk-reduction makes it worthwhile?Semantic proximity Read ↗

Risk-reducing mastectomy perceptions and decision-making among women at high risk of breast cancerSemantic proximity Read ↗

Women’s intentions to engage in risk-reducing behaviours after receiving personal ovarian cancer risk information: an experimental survey studySemantic proximity Read ↗

Decision aids for female BRCA mutation carriers: a scoping review protocol.Semantic proximity Read ↗

Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.Semantic proximity Read ↗

BRCA carriers after risk-reducing bilateral salpingo-oophorectomy: menopausal hormone therapy knowledge gaps, and the impact of physicians' recommendations.Semantic proximity Read ↗

Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.